
The 36-month CORE-VNS study findings showed sustained seizure reduction, improved quality of life, and reduced seizure-related hospitalizations among people with drug-resistant epilepsy receiving vagus nerve stimulation therapy.
New research found over a quarter of children with treatment-refractory epilepsy sustained treatment response to CBD over four years.



